Severity
Critical
FDA Drug recall · Reported May 1, 2024
Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancemen…
Fa Online Inc recalled ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister… - a critical-severity action.
ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister… was recalled by Fa Online Inc in May 1, 2024. Reason: Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient foun…. Check the official notice for the remedy. Verify recall #D-0470-2024 with the FDA Drug before acting.
The recall
Fa Online Inc issued this critical-severity FDA Drug recall-Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient foun….
Sourced from official FDA Drug enforcement records. Verify recall #D-0470-2024 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0470-2024) was formally reported on May 1, 2024, with the manufacturer initiating the action on February 12, 2024. It is classified under Critical severity (Class I), with a current status of Terminated. Fa Online Inc is listed as the recalling firm, operating out of Fresh Meadows, NY. Federal records list the affected scope as 400 capsules.
The documented reason for this recall is: Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this unapproved drug. Distribution data in the federal record shows the product reached: USA Nationwide. The product was sold via Amazon Market Place.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 14,287 drugs & medications recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
400 capsules
Related Recalls
6
5 from same agency
ForeverMen Natural Energy Boost Capsules, packaged in a box containing a 10-count blister card.
Marketed Without an Approved NDA/ANDA: Product was found to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this unapproved drug.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-0470-2024 |
| Date reported | May 1, 2024 |
| Date initiated | February 12, 2024 |
| Recalling firm | Fa Online Inc |
| Firm location | Fresh Meadows, NY |
| Affected scope | 400 capsules |
| Distribution | USA Nationwide. The product was sold via Amazon Market Place. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Lupin Pharmaceuticals Inc. · 2026-05-27
Compare this recall with PRED MILD, prednisolone acetate ophthalmic suspension, USP,… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported May 1, 2024. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.